Clinical Trial Update: A Phase II Trial Comparing Gemcitabine and Pazopanib Versus Gemcitabine and Docetaxel for Patients With Advanced Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase II trial comparing gemcitabine with pazopanib versus gemcitabine with docetaxel for advanced soft tissue sarcoma has completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)
• Pazopanib (Pazopanib)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2020-04-06